Clinical Trials Sponsored by Institut Cancerologie de l'Ouest

Total 343 results

Institut de Cancérologie de Lorraine

Completed

Efficacity of a Standardized Hypnotic Message During the Application of a Qutenza (Capsaicin) 8% Patch (ENHYZA)

Pain

France
Institut de Cancérologie de Lorraine

Completed

Mastectomy in Ambulatory Breast Surgery (MASTAMBU)

Mastectomy

France
Institut de Cancérologie de Lorraine

Completed

Interest of Fluorescence in Salvage Surgery for Recurrence of Head and Neck Cancer in Irradiated Area (SALVADS-Fluo)

Head and Neck Cancer

France
Institut de Cancérologie de Lorraine

Completed

Validation of Endoscopic Bimodal Imager for the Bladder Cancer Detection (CyPaM2)

Bladder Cancer

France
Institut de Cancérologie de Lorraine

Completed

Place of General Medical During Oncology Care Management (MGPEC_Onco)

Oncologic Disorders

France
Institut de Cancérologie de Lorraine

Completed

RNA and Heat Shock Protein Biomarkers in Radiation-induced Fibrosis in Breast Cancer (SPLICI-Rad)

Fibrosis | Breast Carcinoma

France
Institut de Cancérologie de Lorraine

Completed

5 Years Follow-up With Adjuvant Therapy for Women With Breast Invasive Carcinoma (HACAMI)

Breast Cancer

France
Institut de Cancérologie de Lorraine

Completed

Feasibility Study of Supine Breast MRI : Comparison With Prone MRI and Comfort Assessment

Breast Diseases
Institut de Cancérologie de Lorraine

Completed

A Study to Compare Adjuvant Concurrent Chemoradiation (CCRT) to Adjuvant Radiation Therapy (RT) in Grade 2 and 3 Extremity Soft Tissue Sarcomas

Sarcoma,Soft Tissue
Institut de Cancérologie de Lorraine

Completed

Hypofractionated Stereotactic Radiation Therapy of Brain Metastases: Evaluation of Whole-brain Radiotherapy

Brain Metastasis

France
Institut Cancerologie de l'Ouest
Eli Lilly and Company; Novartis; AstraZeneca; European Regional Development Fund

Recruiting

Clinico-biological Data Collection Study of Metastatic Breast Cancer (EPICURE_SEIN)

Breast Cancer

France
Institut de Cancérologie de Lorraine

Recruiting

Intraoperative Assessment of Surgical Margins Using Confocal Microscopy in Comparison With Reference Extemporaneous Examination (HISTOBLOC)

Squamous Cell Carcinoma of Head and Neck | Basal Cell Carcinoma of Skin

France
Institut de Cancérologie de Lorraine

Recruiting

Effectiveness of autoHYpnosis in the Prevention of Anxiety During Radiotherapy of Head and Neck Tumors (HYMACO) (HYMACO)

Head and Neck Tumors

France
Institut de Cancérologie de Lorraine

Active, not recruiting

Using Liquid Biopsy in Newly Diagnosed Patients With High Grade Adenocarcinoma of Ovarian Origin, Fallopian Tubes or Primary Peritoneal (BOVARY CE)

Ovarian Cancer

France
Institut de Cancérologie de Lorraine

Completed

Meditation and Cancer, Pilot Feasibility Study (MAEva Pilot Study)

Breast Cancer | Prostate Cancer

France
Institut de Cancérologie de Lorraine

Completed

CIrCuLAting Dna ESr1 Gene Mutations Analysis (CICLADES)

Breast Cancer

France
Institut de Cancérologie de Lorraine

Completed

Therapeutic Drug Monitoring of BRAF-mutated Advanced Melanoma (OPTIMEL)

Melanoma (Skin)

France
Institut de Cancérologie de Lorraine

Completed

Contribution of Hypnosis to Anxiety and Pain in Brachytherapy Patients (HYCUDES)

Cancer | Brachytherapy

France
Institut de Cancérologie de Lorraine

Terminated

Description of Individual Radiosensitivity With Molecular Biomarkers in a Pediatric Oncology Population (ARPEGE BioM)

Cancer-related Problem/Condition

France
Institut de Cancérologie de Lorraine

Completed

Dose Optimization in 3D Pulsed Dose Rate Brachytherapy for Patients With Locally Advanced Cervical Cancer (TRIDICOL)

Cervical Adenocarcinoma | Stage IB Cervical Cancer | Stage III Cervical Cancer | Stage II Cervical Cancer

France
Institut de Cancérologie de Lorraine

Completed

Evaluation of the Efficacy of Estramustine in Patient With Breast Cancer Progression After Treatment With Aromatase Inhibitor. (EFESE)

Breast Cancer

France
Institut de Cancérologie de Lorraine

Completed

Metastatic Breast Carcinoma and Women Sexual Quality of Life (SexoMBC)

Metastatic Breast Carcinoma

France
Institut de Cancérologie de Lorraine

Completed

Effect of Bladder Distension on Dosimetry in Brachytherapy of Cervical Cancer (VESICOL)

Cervical Cancer

France
Institut de Cancérologie de Lorraine

Completed

Validation of a Medical Device, a Mobile Spectrofluorimeter, Measuring Skin Autofluorescence in Healthy Volunteers. (PHOTOFLUO)

Healthy Volunteers

France
Institut de Cancérologie de Lorraine

Completed

Feasibility Study of Breast MRI in Decubitus Position (EFIMED)

Breast Cancer

France
Institut de Cancérologie de Lorraine

Completed

Use of Compressed Sensing in Breast MRI (COMPRIM)

Breast Cancer

France
Institut de Cancérologie de Lorraine

Completed

HCC Response Assessment by MRI After SBRT

Carcinoma, Hepatocellular
Institut de Cancérologie de Lorraine

Recruiting

Psycho-social Determinant for Sport Practised During Cancer (PERTINENCE)

Cancer | Physical Activity

France
Institut de Cancérologie de Lorraine

Completed

Artificial Intelligence to Search for Abnormalities in Ambulatory Cancer Patients (IASAAC)

Solid Tumor

France
Institut de Cancérologie de Lorraine

Active, not recruiting

Neoadjuvant mFolfirinox With or Without Preoperative Concomitant Chemoradiotherapy in Patients With Borderline Resectable Pancreatic Carcinoma (PANDAS-PRODIGE 44)

Pancreatic Carcinoma

France
Institut de Cancérologie de Lorraine

Completed

SexoMBC2 Non Interventional Study (SexoMBC2)

Quality of Life | Breast Cancer | Sexual Behavior

France
Institut de Cancérologie de Lorraine

Completed

Fluorescence for Sentinel Lymph Node Identification in Cancer Surgery (GASVERT)

Head and Neck Cancer | Breast Carcinoma | Cervix Cancer | Melanoma (Skin) | Ovary Cancer | Rectum Cancer | Endometrium Cancer | Vulva Cancer | Squamous Cell Carcinoma, Skin | Anus Cancer

France
Institut de Cancérologie de Lorraine

Terminated

Conversational Hypnosis in Women Undergoing Imaging for Breast Cancer (HYCOREMA)

Breast Cancer

France
Institut de Cancérologie de Lorraine

Completed

Agreement Between Oral and Cervical Human Papillomavirus Infection in a French Cohort (PAPILLOR)

Human Papillomavirus-Related Cervical Carcinoma

France
Institut de Cancérologie de Lorraine

Completed

HE4 as a Relapse Biomarker in Ovarian Cancers (PRONOV4IR)

Ovarian Carcinoma

France
Institut de Cancérologie de Lorraine

Completed

Determination of the Feasibility of Tumoural Somatic Mutations Detection in Blood of Patients With Ovarian Cancer (BOVARY Pilot)

Ovarian Cancer

France
Institut de Cancérologie de Lorraine

Completed

CaptHPV : Validation of the Method "CaptHPV" for the Diagnosis of Human Papillomavirus Associated Infiltrating Carcinomas (CaptHPV)

Cervical Cancer | Vulvar Cancer | Anal Cancer | Oropharynx Cancer | Oral Cavity Cancer | Penis Cancer

France
Institut de Cancérologie de Lorraine

Completed

Detection of KRAS, NRAS et BRAF Mutations in Plasma Circulating DNA From Patients With Metastatic Colorectal Cancer (ColoBEAM)

Colorectal Cancer Metastatic

France
Institut de Cancérologie de Lorraine

Completed

Interest of Self-compression Technique on Tolerance of Mammography (ITACTs)

Breast Cancer

France
Institut de Cancérologie de Lorraine

Completed

Technical Optimization of Detection of KRAS, BRAF and NRAS Mutations on Tumor DNA Circulating in Metastatic Colorectal Cancer (CircuLOR-1)

Metastatic Colorectal Cancer

France
Institut de Cancérologie de Lorraine

Completed

Understanding Low Gynecological Cancer Delay and Help-seeking Behavior in Older Patients. (CODEGY65)

Gynecologic Cancer | Aged | Symptoms and Signs

France
Institut de Cancérologie de Lorraine

Completed

Detection in Peripheral Blood of Circulating Tumor Cells in Patient With Head and Neck Squamous Cell Carcinoma (CTCVADS)

Head and Neck Cancer

France
Institut de Cancérologie de Lorraine

Completed

Prognostic Impact of Programmed Death Ligand-1 Expression in Advanced Endometrial Cancer

Endometrial Cancer
Institut de Cancérologie de Lorraine

Completed

Sarcopenia is an Independent Prognostic Factor for Overall Survival in Patients With Pancreatic Adenocarcinoma

Pancreatic Neoplasms
Institut de Cancérologie de Lorraine

Completed

Intensity-modulated Radiation Therapy From 70Gy to 80Gy in Localized Prostate Cancer

Prostate Cancer
Institut de Cancérologie de la Loire

Completed

Therapeutic Education Intervention in Breast Cancer: PEPs Hormonotherapy (PEPs HORMONO)

Breast Cancer

France
Institut de Cancérologie de la Loire

Completed

Assessment of Human Herpes Virus Reactivation 6 Post Autologous Stem Cells (VIRAUTO6)

Hematologic Diseases

France
Institut de Cancérologie de la Loire

Completed

Risk Factors for Thromboembolic and Infectious Complications Related to Percutaneous Central Venous Catheters in Cancer - Prospective Multicenter Study (ONCOCIP)

Cancer

France
Institut de Cancérologie de la Loire

Completed

Screening for Social Weaknesses and Coordination Course of Cancer Patients (DEFCOCANCERO)

Cancer

France
Institut de Cancérologie de la Loire

Completed

Feasibility Study of an Intervention Therapeutic Education for Patients Treated With Androgen Deprivation (Nutriprophy)

Prostate Cancer

France

3

Subscribe